BioNTech Q3 Earnings Review: Good Quarter, Strong Promise -- But Still A Hold

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.I have been a little lukewarm on BioNTech SE (NASDAQ: BNTX ), the Mainz, Germany-based Pharma, in previous notes on the company. These included covering Q2 earnings, discus ...